Osteomyelitis
📧 Sign up to get email alerts when something new happens for Osteomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones [NA]
A clinical trial evaluating Cerament-G, a gentamicin-eluting bone substitute, for the treatment of chronic osteomyelitis of long bones; recr…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections
The completed clinical trial evaluated the predictive value of Nu.Q biomarkers to guide the management of osteoarticular infections, includi…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Evaluation of VSS Antibiotic Prophylaxis in Prosthetic Surgery (MRSA)
This clinical trial update describes the evaluation of VSS antibiotic prophylaxis in prosthetic surgery to prevent MRSA infections related t…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute [NA]
A clinical trial is evaluating surgical treatment of osteoarticular infections using a bioactive bone substitute, sponsored by Federal Unive…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections [NA]
Clinical trial assessing next-generation sequencing for detecting and quantifying pathogens in pediatric musculoskeletal infections, with co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections [Phase 4]
Phase 4 trial update examining dalbavancin for Gram-positive osteoarticular infections completed.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis [Phase 3]
Phase 3 trial update evaluating vancomycin or trimethoprim/sulfamethoxazole for MRSA osteomyelitis has completed.
-
FDA approval · 2021-11-18FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved vancomycin hydrochloride as a generic drug under an Original Application from Slate Run Pharmaceuticals, LLC.
-
FDA approval · 2021-11-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (Plano Pharmaceuticals Inc.)
The FDA approved a supplemental application for Vancomycin hydrochloride by Plano Pharmaceuticals Inc., approving changes to the approved dr…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children [Phase 1, Phase 2]
Phase 1/2 trial evaluating ceftaroline for hematogenously acquired Staphylococcus aureus osteomyelitis in children has completed with result…
-
CLINICAL_TRIALS research · 2021-05-18Clinical Trial Update: Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization
Clinical trial update characterizing Acinetobacter baumannii-related osteomyelitis, including clinical and epidemiological findings.
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections [Phase 2, Phase 3]
Phase 2/3 trial update for oral sodium fusidate (CEM-102) in refractory bone or joint infections has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Ceftriaxone as Home IV for Staph Infections [Phase 4]
Phase 4 clinical trial evaluating home intravenous ceftriaxone for Staphylococcal infections, including osteomyelitis, under investigation.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI [Phase 2]
Phase 2 clinical trial updating the use of ferumoxytol-enhanced MRI to differentiate bone sarcomas from osteomyelitis.
-
FDA approval · 2019-06-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the vancomycin hydrochloride original application for Slate Run Pharmaceuticals, enabling a generic version of this antibiotic.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
A completed clinical trial evaluating the use of cefoxitin in continuous parenteral combination therapy for bone and joint infections.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Chronic Infections on Articular Prostheses With C. Acnes Diagnosed by Specific PCR
Completed clinical trial evaluating a specific PCR method to diagnose chronic infections on articular prostheses caused by Cutibacterium acn…
-
FDA approval · 2019-02-15FDA Approved: TYZAVAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved TYZAVAN (vancomycin) from Hikma Pharmaceuticals USA Inc. under an Original Application (NDA211962). This marks the brand’s offi…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection
Completed clinical trial update addressing denosumab-related bone and joint infection and osteomyelitis, including adverse events observed i…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis [Phase 2]
Phase 2 trial comparing dalbavancin to an active comparator for osteomyelitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis [Phase 2]
Phase 2 trial comparing dalbavancin to an active comparator in adult osteomyelitis; study terminated with results posted in 2018.
-
FDA approval · 2018-07-10FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for vancomycin hydrochloride from Mylan Institutional LLC, confirming its use for treating serious infe…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis [Phase 2]
Phase 2 trial evaluating oral versus intravenous antibiotics for osteomyelitis has terminated, with results posted on 2018-06-08.
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis
A completed clinical trial evaluated procalcitonin as a diagnostic and monitoring biomarker for osteomyelitis, particularly in patients with…